R. S. Weening

652 total citations
16 papers, 530 citations indexed

About

R. S. Weening is a scholar working on Immunology, Molecular Biology and Physiology. According to data from OpenAlex, R. S. Weening has authored 16 papers receiving a total of 530 indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Immunology, 7 papers in Molecular Biology and 3 papers in Physiology. Recurrent topics in R. S. Weening's work include Neutrophil, Myeloperoxidase and Oxidative Mechanisms (9 papers), S100 Proteins and Annexins (5 papers) and Erythrocyte Function and Pathophysiology (2 papers). R. S. Weening is often cited by papers focused on Neutrophil, Myeloperoxidase and Oxidative Mechanisms (9 papers), S100 Proteins and Annexins (5 papers) and Erythrocyte Function and Pathophysiology (2 papers). R. S. Weening collaborates with scholars based in Netherlands, United States and Belgium. R. S. Weening's co-authors include Dirk Roos, Ben G.J.M. Bolscher, Rob van Zwieten, Martin de Boer, Reinhard Seger, AJ Verhoeven, Jeanette H.W. Leusen, P. M. Hilarius, Mic N. Hamers and René Lutter and has published in prestigious journals such as The Lancet, Journal of Biological Chemistry and Journal of Clinical Investigation.

In The Last Decade

R. S. Weening

15 papers receiving 515 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
R. S. Weening Netherlands 10 430 201 176 62 45 16 530
C.S. Awtrey United States 7 60 0.1× 214 1.1× 34 0.2× 20 0.3× 28 0.6× 11 392
Ilse Dingjan Netherlands 11 225 0.5× 221 1.1× 25 0.1× 19 0.3× 30 0.7× 12 509
Clawson Cc United States 10 194 0.5× 135 0.7× 50 0.3× 19 0.3× 4 0.1× 13 394
Ruth Epstein United States 8 338 0.8× 127 0.6× 20 0.1× 15 0.2× 23 0.5× 9 494
R L Olsen Norway 8 206 0.5× 80 0.4× 126 0.7× 12 0.2× 4 0.1× 8 356
Martine Hamel Canada 11 77 0.2× 156 0.8× 51 0.3× 21 0.3× 57 1.3× 12 423
Ronald J. Helmke United States 10 96 0.2× 161 0.8× 42 0.2× 7 0.1× 15 0.3× 14 414
Hermann von Grafenstein United States 12 212 0.5× 210 1.0× 91 0.5× 13 0.2× 24 0.5× 16 581
B T Keller United States 9 74 0.2× 198 1.0× 65 0.4× 11 0.2× 16 0.4× 12 441
Michele Fontaine United States 7 114 0.3× 113 0.6× 77 0.4× 117 1.9× 9 0.2× 9 421

Countries citing papers authored by R. S. Weening

Since Specialization
Citations

This map shows the geographic impact of R. S. Weening's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by R. S. Weening with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites R. S. Weening more than expected).

Fields of papers citing papers by R. S. Weening

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by R. S. Weening. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by R. S. Weening. The network helps show where R. S. Weening may publish in the future.

Co-authorship network of co-authors of R. S. Weening

This figure shows the co-authorship network connecting the top 25 collaborators of R. S. Weening. A scholar is included among the top collaborators of R. S. Weening based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with R. S. Weening. R. S. Weening is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

16 of 16 papers shown
1.
Leusen, Jeanette H.W., C. Meischl, Michel H. M. Eppink, et al.. (2000). Four novel mutations in the gene encoding gp91-phox of human NADPH oxidase: consequences for oxidase assembly.. PubMed. 95(2). 666–73. 34 indexed citations
2.
Leusen, Jeanette H.W., Ben G.J.M. Bolscher, P. M. Hilarius, et al.. (1994). 156Pro-->Gln substitution in the light chain of cytochrome b558 of the human NADPH oxidase (p22-phox) leads to defective translocation of the cytosolic proteins p47-phox and p67-phox.. The Journal of Experimental Medicine. 180(6). 2329–2334. 91 indexed citations
3.
Zegers, B.J.M., et al.. (1994). [Immunodeficiency in The Netherlands: clinical and immunological survey, 1970-1983. Interfacultaire werkgroep Immunodeficiëntie].. PubMed. 138(7). 354–9. 1 indexed citations
4.
Leusen, Jeanette H.W., Martin de Boer, Ben G.J.M. Bolscher, et al.. (1994). A point mutation in gp91-phox of cytochrome b558 of the human NADPH oxidase leading to defective translocation of the cytosolic proteins p47-phox and p67-phox.. Journal of Clinical Investigation. 93(5). 2120–2126. 91 indexed citations
5.
Monnens, L.A.H., et al.. (1993). Contribution to scientific research in paediatrics in The Netherlands: evaluation according to subspeciality over a 10-year period. European Journal of Pediatrics. 152(11). 870–872.
6.
Fischer, Alain, Anthony W. Segal, Reinhard Seger, & R. S. Weening. (1993). The management of chronic granulomatous disease. European Journal of Pediatrics. 152(11). 896–899. 41 indexed citations
7.
Boer, Martin de, Johann Peter Hossle, Reinhard Seger, et al.. (1992). Cytochrome b558-negative, autosomal recessive chronic granulomatous disease: two new mutations in the cytochrome b558 light chain of the NADPH oxidase (p22-phox).. PubMed. 51(5). 1127–35. 49 indexed citations
8.
Bolscher, Ben G.J.M., Rob van Zwieten, I M Kramer, et al.. (1989). A phosphoprotein of Mr 47,000, defective in autosomal chronic granulomatous disease, copurifies with one of two soluble components required for NADPH:O2 oxidoreductase activity in human neutrophils.. Journal of Clinical Investigation. 83(3). 757–763. 77 indexed citations
9.
Smitt, J.H. Sillevis, et al.. (1988). [Discoid lupus erythematosus and other clinical manifestations in female carriers of chronic granulomatous disease].. PubMed. 132(1). 18–21. 1 indexed citations
10.
Weening, R. S., L Corbeel, Martin de Boer, et al.. (1985). Cytochrome b deficiency in an autosomal form of chronic granulomatous disease. A third form of chronic granulomatous disease recognized by monocyte hybridization.. Journal of Clinical Investigation. 75(3). 915–920. 67 indexed citations
11.
Lutter, René, Rob van Zwieten, R. S. Weening, Mic N. Hamers, & Dirk Roos. (1984). Cytochrome b, flavins, and ubiquinone-50 in enucleated human neutrophils (polymorphonuclear leukocyte cytoplasts).. Journal of Biological Chemistry. 259(15). 9603–9606. 48 indexed citations
12.
Wever, R., et al.. (1982). Characterization of the Peroxidase in Human Eosinophils. Advances in experimental medicine and biology. 141. 501–508. 9 indexed citations
13.
Weening, R. S., et al.. (1979). Phenylglyoxal is not a selective inhibitor of phagocytosis. Journal of Cell Science. 38(1). 331–343. 4 indexed citations
14.
Wever, R., et al.. (1976). An EPR study of myeloperoxidase in human granulocytes. Biochimica et Biophysica Acta (BBA) - General Subjects. 421(2). 328–333. 15 indexed citations
15.
Weening, R. S., et al.. (1976). A defect in the initiation of the metabolic stimulation during phagocytosis of human granulocytes. Inflammation Research. 6(1-3). 281–281. 1 indexed citations
16.
Weening, R. S., et al.. (1975). GRANULOCYTE FUNCTION AND OPSONINS. The Lancet. 306(7938). 773–773. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026